StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

1-[(Dimethylamino)methyl]-1-methylpropylbenzoat

Amylocaine

HCID 10767
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
644-26-8
Standard-SMILES
CCC(C)(CN(C)C)OC(=O)c1ccccc1
InChIKey
FDMBBCOBEAVDAO-UHFFFAOYSA-N
Summenformel
C14H21NO2
Durchschnittliche Molmasse
235,32 g/mol
Monoisotopische Masse
235,15722891

Überblick

Stovaine is a benzoate ester.

Namen und Bezeichner

Bevorzugter Name
Amylocaine
IUPAC
[1-(dimethylamino)-2-methylbutan-2-yl] benzoate
Lokaler Name
1-[(Dimethylamino)methyl]-1-methylpropylbenzoat
Englischer Name
1-[(dimethylamino)methyl]-1-methylpropyl benzoate
Summenformel
C14H21NO2
Molmasse
235.32

Namen und Synonyme

AmylocaineStovaine644-26-8QRW683O56T1-(DIMETHYLAMINO)-2-METHYL-2-BUTANOL BENZOATEDTXSID6047862(1-((dimethylamino)methyl)-1-methyl-propyl) benzoate[1-[(dimethylamino)methyl]-1-methyl-propyl] benzoateRefChem:557965DTXCID2027838211-411-1Amyleine
Weitere Namen anzeigen
Stovain2-Butanol, 1-(dimethylamino)-2-methyl-, 2-benzoateBenzoic acid 1-[(dimethylamino)methyl]-1-methylpropyl ester
Amylocaine [BAN]1-(Dimethylamino)-2-methylbutan-2-yl benzoate[1-(dimethylamino)-2-methylbutan-2-yl] benzoateEINECS 211-411-1Amylocaine (BAN)1-[(Dimethylamino)methyl]-1-methylpropyl benzoate1-((Dimethylamino)methyl)-1-methylpropyl benzoate2-Butanol, 1-(dimethylamino)-2-methyl-, benzoate

Datenbank-Bezeichner

CAS
644-26-8
PubChem CID
10767
DTXSID

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
3
Polarare Oberfläche (TPSA)
29,5 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
6
Schwere Atome
17
Formalladung
0
Komplexität
247

Experimentelle und physikochemische Eigenschaften

Human DrugsPharmaceuticals

Physikochemische Eigenschaften

Siedepunkt
377.72 °C · 377.72°C (rough estimate)
Dichte
1.0247 · 1.0247 (rough estimate)
Brechungsindex
1.5385 · 1.5385 (estimate)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Sicherheitsdaten

Toxizität
LDLo ivn-rat: 25 mg/kg PHREA7 12,262,32

Chemie und Industrie

Pharmakologische Informationen

Protein BindingA lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.
Pharmacodynamics · 1 Eintrag

Like all other local anesthetics, amylocaine acts as a membrane stabilizing drug that reversibly decreases the rate of depolarization and depolarization of excitable membranes. In this way, the conduction of neuronal signals for certain bodily movements can be blocked. In particular, when administered for spinal anesthesia, the resultant anesthesia can typically extend from the chest to the legs.

Mechanism of Action · 1 Eintrag

In particular, amylocaine, much like other local anesthetics, bind and blockade voltage gated sodium channels located in the excitable membranes of various sensory receptors. Once blocked, the influx of sodium across the channels and membrane is inhibited. Because the influx of sodium is necessary to facilitate neuronal action potentials and signal conduction across sensory receptor membranes, the influx inhibition subsequently prevents the body reactions that would normally result from the neuronal signals.

Biological Half-LifeA lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.
Metabolism/MetabolitesA lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.
Absorption, Distribution and Excretion · 4 Einträge

A lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.

A lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
DTXSID6047862
ChEMBL
CHEMBL1740065
ChEBI
CHEBI:34981
UNII
QRW683O56T
EC Number
211-411-1
Nikkaji
J13.802I

A lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.

A lack of detailed information regarding the specificities of amylocaine relate to a lack of information on its pharmacokinetics at the time of its primary use in the early 1900s.

Verwendung und Herstellung

Use ClassificationPharmaceuticals

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

1-Chloro-2-methyl-2-butanol